Home > Insider Trading > Filing (0001209191-23-058994)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651311	Merus N.v.	MRUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1790314	B. Peter Silverman	C/O Merus N.v. Uppsalalaan 17 Utrecht P7 3584 CT	Coo & Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2023-12-15	21,100	$0.00	21,100	No	4	M	Direct
Common Shares	Acquisiton	2023-12-15	1,286	$0.00	22,386	No	4	M	Direct
Common Shares	Disposition	2023-12-15	22,386	$25.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Share Option (right to buy)	Disposition	2023-12-15	21,100	$0.00	21,100	$11.16
Common Shares	Share Option (right to buy)	Disposition	2023-12-15	1,286	$0.00	1,286	$12.37

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-02-20	No	4	M	Direct
0		2030-04-16	No	4	M	Direct

Footnotes

Represents the exercise price of the options originally granted on February 20, 2019.
Represents the exercise price of the options originally granted on April 16, 2020.
Amount represents the weighted average price of shares sold, which ranged from $25.02 to $25.00. Details of individual transactions are available upon request.
Options vest over a four-year period commencing February 20, 2019. 25% vest after one year and in 36 equal monthly installments thereafter.
Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on February 20, 2019.
Options vest over a four-year period commencing April 16, 2020. 25% vest after one year and in 36 equal monthly installments thereafter.
Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on April 20, 2020.